Answers are grounded in this paper and cite their sources.
Von Recklinghausen's disease (VRH) or neurofibromatosis type 1 (NF1) is a rare phacomatosis caused by autosomal dominant mutation affecting the neurofibromatosis gene located on chromosome 17 (17q11.2.) and with a prevalence of 0.02 to 0.03% [1,2].Thus mutated fibromine would be unable, as a tumor suppressor, to control the maturation and proliferation of glial and neuronal cells, which explains the frequent development of neurological tumors (glioma, neuroma, and neurofibroma), which are the main signs of this disease [1-3].Other clinical manifestations may be associated with these neurological tumors: cutaneous, bone, endocrine, cardiac, vascular, and ocular involvement signing the systemic nature of this disease and making its diagnosis sometimes a real challenge for the clinician [2,4].Among the possible neurological manifestations during this phacomatosis, peripheral facial paralysis remains exceptional, classically affects the child, and often associated to degeneration with the development of malignant tumors of the nerve sheaths [5][6][7].We are reporting an original observation of PFP revealing VRH in adult subject.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: